Al-Dawaa Medical Services Company (TADAWUL:4163)

Market Cap	4.13B -41.7%
Revenue (ttm)	6.74B +4.4%
Net Income	321.76M -8.4%
EPS	3.79 -8.4%
Shares Out	85.00M
PE Ratio	12.85
Forward PE	11.77
Dividend	2.52 (5.18%)
Ex-Dividend Date	May 11, 2026

Volume	142,405
Average Volume	217,764
Open	48.58
Previous Close	48.30
Day's Range	47.98 - 48.64
52-Week Range	46.02 - 81.10
Beta	-0.07
RSI	49.54
Earnings Date	Apr 28, 2026

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia and Kingdom of Bahrain. The company offers medicines, perfumes, cosmetics, beauty tools, and other pharmaceutical products; and transportation and logistics services. It is also involved in online wholesale of pharmaceutical products, pharmaceutical agents, wholesale of pharmaceutical goods, related pharmacy activities, pharmaceutical warehousing activities, retail of medical equipment and other...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2025, TADAWUL:4163's revenue was 6.74 billion, an increase of 4.37% compared to the previous year's 6.45 billion. Earnings were 321.76 million, a decrease of -8.44%.